Quick Win By the Algorithm: PLX is on its way
Quick Win By the Algorithm
On January 27, 2017, the I Know First algorithm had predicted a bullish forecast for Protalix BioTherapeutics, Inc. (PLX). PLX had a signal of 271.73 and a predictability of 0.2. Therefore, in accordance with the Quick Win By the Algorithm, the company reported gain of 80.36% in just 14 days.
Protalix BioTherapeutics, Inc. (PLX) is a biopharmaceutical company. It focuses on the development and commercialization of therapeutic proteins based on its proprietary ProCellEx protein expression system. The company operates in Israel and internationally.
2017 is to be the year of PLX: new collaborations, new partnerships and new agreements. Actually, the game already started. Indeed, Knight Therapeutics acquired 6.2 million shares of Protalix BioTherapeutics (PLX) at the end of January.
Therefore, it enabled the stocks of the biotech company to skyrocket. Moreover, the stock surpassed its 52-week high price of $0.97 on February 09, 2017. This created a strong incentive to buy among other investors. As the earnings of PLX approach, the stock will remain volatile until the release of the results. Depending on it, investors decision to pursue or not their investments in the company is at stake.
This bullish forecast on PLX was sent to current I Know First subscribers on January 27, 2017.
Before making any trading decisions, consult the latest forecast as the algorithm constantly updates predictions daily. While the algorithm can be used for intra-day trading the predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.
